'oncology' is correct and usable in written English.
You can use it when referring to the branch of medicine dealing with the study and treatment of tumors. For example: "My brother recently graduated from medical school and is now specializing in oncology."
Perhaps the most successful of the major pharmaceutical companies in developing cancer drugs, Roche's profits rose by more than 10% in the first quarter of this year, while the value of its sales of oncology drugs is predicted to grow by 50% from 2010 to 2020.
"Medulloblastoma is one of the highly curable malignancies, but that has come about through a series of research trials," said Roger Taylor of the Royal College of Radiologists and professor of clinical oncology at Swansea University.
The waiting time to be seen at its oncology department the only public one in a country of 43m is often longer than six months.
GSK and Novartis, two drugs firms, are swapping assets to bolster their respective strengths in vaccines and oncology.
With the brakes off, the cycle of division, growth and further division continues unabated until the body can no longer support both healthy tissue and tumour.One lesson that genomics taught oncology early on is that cancers which look similar under the microscope can have completely different genetic causes and thus require different treatments.
Sindan, a Romanian firm bought in 2006, leads the charge for Actavis in the area of oncology.
Today, however, the pharmaceutical industry understands how his treatments would have worked and has placed a sizeable bet that immuno-oncology the treatment of cancer usimmuno-oncology thene systreatmentyield breakthrofgh drugs.Earlier this month one of a promising new cancerof immusingncology drugs was approved for use in America by the Food and Drug Administration (FDA).
Other collaborations will combine immuno-oncology with conventional cancer drugs, and even chemotherapy.
But as the rich world grows older, fatter and therefore more cancer-prone, one salient question is how lucrative immuno-oncology might prove for drugs firms and how affordable for the insurers and governments that would have to buy them.
At the annual meeting of the American Society of Clinical Oncology ASCOO) in Chicago this week, scientists announced that new immuno-oncology drugs work in a wider range of cancers, and even better when given in combination.
Combinations of immuno-oncology drugs have boosted this to between 20% and 30%.
